Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19

Showing 19 citing articles:

Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 116
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 2
cGAS-STING signaling in the tumor microenvironment
Ziqi Liu, Dan Wang, Jiarong Zhang, et al.
Cancer Letters (2023) Vol. 577, pp. 216409-216409
Closed Access | Times Cited: 33
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression
Ana Nóbrega, Rafael Sampaio Pimentel, Ana Paula Prado, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 6, pp. 579-594
Closed Access | Times Cited: 8
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Dendritic cells: the yin and yang in disease progression
Carlos Jiménez‐Cortegana, Francisca Palomares, Gonzalo Álba, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access
Dendritic Cell-Based Glioblastoma Vaccines: Advances and Challenges
Zuowen Zhang, Mingchang Li, Jie Huang
IntechOpen eBooks (2025)
Closed Access
Dendritic Cell Vaccines in Cancer Immunotherapy: Expanding Horizons for Solid and Nonsolid Tumors
Farid Ghorbaninezhad, Ahmad Ghorbani, Ashkan Rasouli‐Saravani, et al.
Interdisciplinary cancer research (2025)
Closed Access
Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies
Siwei Wang, Qin Lu, Furong Liu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
The development and function of human monocyte-derived dendritic cells regulated by metabolic reprogramming
Ying Zhao, Cuie Gao, Lu Liu, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 3, pp. 212-222
Closed Access | Times Cited: 7
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy
In-Wook Kim, A‐Rum Yoon, JinWoo Hong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Myeloid-derived suppressor cells: Emerging players in cancer and beyond
Carlos Jiménez‐Cortegana, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xix
Closed Access | Times Cited: 3
Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment
Babak Arjmand, Sepideh Alavi-Moghadam, Golnar Khorsand, et al.
Regenerative Engineering and Translational Medicine (2024)
Closed Access
Can interventions targeting MDSCs improve the outcome of vaccination in vulnerable populations?
Yuliya V. Perfilyeva, Arthur Aquino, M Borodin, et al.
International Reviews of Immunology (2024), pp. 1-17
Closed Access
Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy
Jie Chen, Chao Ji, Silin Liu, et al.
Cancer Pathogenesis and Therapy (2023) Vol. 2, Iss. 4, pp. 299-313
Open Access | Times Cited: 1
Evaluation of Interactions of Triterpenes in M. charantia with Proteins Involved in Vascularization in In Silico
Büşra Sevim, Onur Eroğlu
Biology Bulletin (2023) Vol. 50, Iss. S3, pp. S325-S337
Closed Access
Page 1

Scroll to top